Role of the pathologist in active surveillance for prostate cancer

Abstract

Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostate-specific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Mazzucchelli, R., Galosi, A. B., Santoni, M., Lopez-Beltran, A., Scarpelli, M., Cheng, L., & Montironi, R. (2015). Role of the pathologist in active surveillance for prostate cancer. Analytical and Quantitative Cytopathology and Histopathology, 37(1), 65–68.
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Analytical and Quantitative Cytopathology and Histopathology
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}